ViewRay Announces First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer
Study to Explore Clinical Benefits of Precise, High Dose Radiation Therapy Enabled by MRIdian's MR-guidance Combined with Daily On-table Adaptation in Pancreatic Cancer
CLEVELAND, Jan. 4, 2019 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. ... Devices, Oncology ViewRay, Stereotactic MRI-guided, On-table Adaptive Radiation Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Marketing | Pancreas | Pancreatic Cancer | Pharmaceuticals | Radiation Therapy | Study